MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1021 to 1040 of 166,322 approvalsPage 52 of 8317

Dopamine Hydrochloride Injection

Approval Number: 国药准字H20253682
Registration: Mar 25, 2025
遂成药业股份有限公司

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20253728
Registration: Mar 25, 2025
青岛国信制药有限公司

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253708
Registration: Mar 25, 2025
广州迈凯安生物医药研究院有限公司

Aminophylline Injection

Approval Number: 国药准字H20253717
Registration: Mar 25, 2025
西洲医药科技（浙江）有限公司

Mecobalamin Tablets

Approval Number: 国药准字H20253741
Registration: Mar 25, 2025
湖南千金湘江药业股份有限公司

Pramipexole Dihydrochloride Sustained Release Tablets

Approval Number: 国药准字H20253686
Registration: Mar 25, 2025
植恩生物技术股份有限公司

Metaraminol Bitartrate Injection

Approval Number: 国药准字H20253733
Registration: Mar 25, 2025
安徽美来药业股份有限公司

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20253701
Registration: Mar 25, 2025
上海旭东海普药业有限公司

Minoxidil Liniment

Approval Number: 国药准字H20253678
Registration: Mar 25, 2025
山东百诺医药股份有限公司

Olanzapine Tablets

Approval Number: 国药准字H20253703
Registration: Mar 25, 2025
湖南洞庭药业股份有限公司

Sulfamethoxazole,Sulfadiazine and Trimethoprim Tablets

Approval Number: 国药准字H14023739
Registration: Mar 25, 2025
山西太原药业有限公司

Pentoxifylline Injection

Approval Number: 国药准字H20253677
Registration: Mar 25, 2025
河南朗冠药品制剂研究院有限公司

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20253727
Registration: Mar 25, 2025
青岛国信制药有限公司

Rivastigmine Transdermal Patch

Approval Number: 国药准字HJ20200018
Registration: Mar 25, 2025
Luye Pharma AG

Thioctic Acid Tablets

Approval Number: 国药准字H20253713
Registration: Mar 25, 2025
湖南先施制药有限公司

Nicardipine Hydrochloride Injection

Approval Number: 国药准字H20253729
Registration: Mar 25, 2025
石家庄四药有限公司

Risperidone Tablets

Approval Number: 国药准字H20253706
Registration: Mar 25, 2025
湖南洞庭药业股份有限公司

Iohexol Injection

Approval Number: 国药准字H20253737
Registration: Mar 25, 2025
浙江兄弟药业有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.